VIROLFI (Valganciclovir) Tablets: Uses, Strengths, Safety Information & FAQs

VIROLFI (Valganciclovir) Tablets contain valganciclovir, an antiviral medicine used under medical supervision for certain cytomegalovirus (CMV) infections and for prevention of CMV disease in selected high-risk transplant patients. The medicine is a prescription treatment and should be used only according to the advice of a qualified healthcare professional.

VIROLFI (Valganciclovir) Tablets – Product Details

Valganciclovir is an oral antiviral that is converted in the body to ganciclovir, which inhibits viral DNA replication. It is used in specific clinical situations involving CMV, including treatment of CMV retinitis in certain immunocompromised adults and prevention of CMV disease in high-risk kidney, heart, and kidney-pancreas transplant recipients.

The exact indication, treatment duration, and monitoring requirements depend on the patient's condition, immune status, kidney function, blood counts, and other medicines being taken.

VIROLFI Strength

VIROLFI (Valganciclovir) Tablets – 450 mg

The commonly documented tablet strength of valganciclovir is 450 mg. Tablets should be taken exactly as prescribed. Official prescribing information states that valganciclovir tablets should be taken with food and should not be broken or crushed.

What Is VIROLFI (Valganciclovir) Used For?

VIROLFI may be prescribed for specific CMV-related conditions. Depending on the patient's clinical circumstances, valganciclovir tablets are indicated for:

Treatment of CMV retinitis in certain adults with AIDS.

Prevention of CMV disease in high-risk kidney, heart, and kidney-pancreas transplant recipients.

Prevention of CMV disease in certain high-risk pediatric transplant patients, where appropriate prescribing information applies.

It is important not to use valganciclovir simply because a person has symptoms that might resemble a viral infection. CMV management requires appropriate medical assessment and, where indicated, laboratory testing.

VIROLFI Dosage and Administration

The appropriate valganciclovir dosage varies according to the indication and patient characteristics. Kidney function is particularly important, because dosage adjustments are required in adults with renal impairment.

Patients should not change the dose, stop treatment, or extend treatment without medical advice. A doctor may also recommend blood-count and kidney-function monitoring during treatment.

Important Safety Information

Valganciclovir has important safety warnings. It can cause serious reductions in blood-cell counts, including neutropenia, anemia, thrombocytopenia, pancytopenia, and bone-marrow failure. Kidney injury can also occur, particularly in people with renal impairment, dehydration, advanced age, or exposure to other medicines that may affect the kidneys.

Valganciclovir may also affect fertility and can cause fetal harm based on available evidence. Pregnancy, breastfeeding, fertility considerations, kidney disease, blood disorders, and concomitant medicines should therefore be discussed with the prescribing doctor before treatment.

VIROLFI Tablets Online in India

Patients looking for VIROLFI (Valganciclovir) Tablets online in India should use a legitimate, licensed pharmacy or healthcare provider and have a valid prescription where required. Because valganciclovir requires individualized dosing and medical monitoring, online availability should not replace consultation with a doctor.

Frequently Asked Questions

1. What is VIROLFI 450 mg used for?

VIROLFI 450 mg contains valganciclovir and may be prescribed for specific CMV infections or CMV prevention in certain high-risk transplant patients.

2. Is VIROLFI a prescription medicine?

Yes. Valganciclovir is a prescription antiviral and should be taken under appropriate medical supervision.

3. Can VIROLFI be taken without a doctor's prescription?

Self-medication is not recommended. The treatment requires consideration of the patient's diagnosis, kidney function, blood counts, and other medicines.

4. Should VIROLFI 450 mg be taken with food?

Yes. Prescribing information recommends taking valganciclovir tablets with food. Tablets should not be broken or crushed.

5. Does VIROLFI require kidney-function monitoring?

Kidney function can affect valganciclovir dosing, particularly in patients with renal impairment, so medical monitoring may be necessary.

6. What should I do if I experience unusual symptoms during treatment?

Contact your healthcare professional promptly, particularly if you develop signs that could indicate infection, bleeding, severe weakness, or other concerning symptoms.

Medical Disclaimer: This page is for general educational information and does not replace professional medical advice, diagnosis, or treatment. VIROLFI (valganciclovir) should be used only under the direction of a qualified healthcare professional.